3 min read
Mass Spectrometry for Complex Biotherapeutics: Q&A with KBI's Mass Spec Team
CDMOs are becoming increasingly important for developers to reach efficient vaccine and complex biotherapeutic development for their advanced...
Presentation | Host Cell Protein Analysis by Mass Spectrometry
Michael J Nold, Ph.D., Mass Spectrometry Core Facility, KBI Biopharma
__
Originally presented at the 2018 Sciex Users Meeting by Michael J Nold, Ph.D., Mass Spectrometry Core Facility, KBI Biopharma.
3 min read
CDMOs are becoming increasingly important for developers to reach efficient vaccine and complex biotherapeutic development for their advanced...
5 min read
Increasing global demand for vaccines and complex biotherapeutics has led to a larger role for Contract Development and Manufacturing Organizations...
1 min read
Case Study | CMO/CDMO Automates Glycan Workflows to Increase Business CapacityWaters Corporation__KBI Biopharma Inc. implemented the Waters UNIFI...